Sep 16 2024 16 mins
David Panzirer, a trustee of the Helmsley Charitable Trust, discovered his calling when his daughter was diagnosed with type 1 diabetes (T1D). A businessperson at his core, David views healthcare grants as investments, and his team continuously develops a deep understanding of the ecosystem as a key success factor to maximize their impact. Learn from one of the most significant players in the field of venture philanthropy, his team’s portfolio approach to healthcare investments, and their singular focus to improve people’s lives living with disease. Sanofi host Eric Racine and co-host Andrew Vilcinskas – a T1D patient himself – discuss with David the intersection of advocacy, philanthropy and business.
The Leona M. and Harry B. Helmsley Charitable Trust is a global philanthropy committed to helping people live better lives today and creating stronger, healthier futures for individuals and communities. They partner with people and organizations to invest in new ideas or research across six program areas. The Type 1 Diabetes (T1D) program is dedicated to helping the global T1D community live safer, better, and more fulfilling lives today while funding advancements in research and technology for a better tomorrow.